Acute Treatment Trial in Adult Subjects With Migraines

NCT03872453 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2154

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Zavegepant
DRUG: Zavegepant matching placebo
DEVICE: Intranasal Aptar Pharma Unit Dose System

Sponsor

Pfizer